Chiron's Suspension Extended
MedImmune Among Firms Rushing to Fill Vaccine Void
By Michael S. Rosenwald
Washington Post Staff Writer
Thursday, December 9, 2004; Page E01
British regulators have extended their suspension of Chiron Corp.'s license to manufacture flu vaccine, jeopardizing the company's ability to sell millions of flu shots in the United States next flu season.
The extended suspension announced late Tuesday means that Chiron, already blocked from shipping 48 million shots to the United States this year, may not be able to resume operations until at least April, a month after the company has indicated it needs to start production for the season that will begin next fall.